Skip to content
  • Svenska
EQL Pharma
  • About us
  • Products
  • Investors
  • Press
  • Vacancies
  • Contact

Investors

Investors

  • Annual General Meeting 2020
  • Stock information
  • Financial calendar
  • Financial reports

Financial reports

2020/2021
Interim Report April-September
Interim Report April-June

2019/2020
Annual Report 2019/2020
Year-end report April 2019 – March 2020
Interim report April-December 2019
Interim report April – September 2019
Interim report April – June 2019

2018/2019
Annual Report 2018/2019
Year-end report April 2018 – March 2019
Interim report October – December 2018
Interim report July – September 2018
Interim report April – June 2018

2017/2018
Annual report 2017/2018
Year End report January 2017 – March 2018
Interim report January – December 2017
Interim report January – September 2017
Interim report January – June 2017
Interim report January – March 2017

2016
Annual Report 2016
Year End report 2016
Interim Report January – September 2016

2015
Interim Report January- December 2015
Interim Report January- September 2015

2014
Annual Report 2014

2013
Annual Report 2013

2012
Annual Report 2012

 

EQL Pharma AB

+46 46 12 01 70
info@eqlpharma.com
Stortorget 1, 222 23 Lund, Sweden

  • Contact
  • Investors
  • Privacy Policy
  • About Cookies

About EQL Pharma

EQL Pharma is an entrepreneurial pharmaceutical company focusing on simplicity and efficiency at all levels of the value chain in order to be able to deliver cost-efficient medicines of highest quality to pharmacies and hospitals, primarily in the Nordic region.

Created by Intervaro Web Agency.

This site uses cookies. By continuing to use the site, you consent to the use of cookies. Read more about cookies on this site.

  • About us
    • Business strategy
    • Vision, mission and values
    • History
    • Management
    • Board
    • Back
  • Products
  • Investors
    • Stock information
    • Financial calendar
    • Financial reports
    • Back
  • Press
    • Press releases
    • Back
  • Vacancies
  • Contact
    • Customer contact
    • Investor contact
    • Contact parallel import
    • Back